AVAI BIO, INC. (AVAI) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2026 | -$1.01M | +13.0% |
| 2025 | -$1.16M | +12.2% |
| 2024 | -$1.32M | -2328.2% |
| 2023 | -$54.5K | -110.2% |
| 2022 | $535.0K | +2217.1% |
| 2021 | $23.1K | -82.3% |
| 2020 | $130.7K | +255.3% |
| 2019 | -$84.2K | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2026 | -$1.01M | +13.0% |
| 2025 | -$1.16M | +12.2% |
| 2024 | -$1.32M | -2328.2% |
| 2023 | -$54.5K | -110.2% |
| 2022 | $535.0K | +2217.1% |
| 2021 | $23.1K | -82.3% |
| 2020 | $130.7K | +255.3% |
| 2019 | -$84.2K | — |